Top Stories
Genmab pays Immatics $54M to form anticancer bispecific pact
16 Jul 2018
Genmab has paid Immatics $54 million (€46 million) to enter into an anticancer bispecific antibody pact. The upfront fee and $550 million ...
Why another Pfizer reorganization? Bigger bets on biosimilars, maybe—or finally a generics selloff
16 Jul 2018
Pfizer’s shaking itself up again, with some moves that have put its branded drug business in charge of two big challenges: biosimilars, wh...
AbbVie, Johnson & Johnson’s Imbruvica comes up short in non-Hodgkin lymphoma trial
16 Jul 2018
With eight FDA-approved indications since 2013, Johnson & Johnson and AbbVie’s Imbruvica hasn’t run into many stumbling blocks. But ...
Amazon, Google, Apple to drive life sciences market to $1.5T by 2022, report says
16 Jul 2018
Partnerships between healthcare organizations and technology giants will propel the global life sciences market to $1.5 trillion by 2022, ac...
Medical device security software startup MedCrypt pulls in $1.9M
16 Jul 2018
Medical device cybersecurity software company MedCrypt announced today that it has raised $1.9 million in new seed funding. The round’s pr...
The Power of Blockchain on Medical Devices and Health Records
16 Jul 2018
Wearable and other mobile medical devices have some pretty marvelous benefits for healthcare, but they come with a couple of troubling side ...
Antibe builds case for GI safety of naproxen alternative
09 Jul 2018
Antibe Therapeutics has posted secondary endpoint data from a phase 2b trial of its alternative to nonsteroidal anti-inflammatory drug napro...
FDA approves Pierre Fabre/Array Biotech melanoma combo
09 Jul 2018
US regulators have issued a green light for Pierre Fabre and Array Biotech’s encorafenib/binimetinib combination therapy for advanced BRAF...
Johnson and Johnson, Mercy to work on medical device project
09 Jul 2018
Mercy is working with Johnson and Johnson Medical Device Companies to enable it to use Mercy’s data platform to track and evaluate the per...
Cash-strapped Titan delays Parkinson’s implant program
09 Jul 2018
Titan Pharmaceuticals has been cleared to start the second phase of a trial of its ropinirole implant for Parkinson’s disease—but will h...
Athenex rakes in $100M, sets up Chinese TCR-focused JV
09 Jul 2018
Just over a year since its IPO, Athenex is broadening its scope—the biotech is picking up a $100 million investment from Perceptive Adviso...
Armed with a brand-new patent, Roche demands royalties on Lilly’s psoriasis drug Taltz
09 Jul 2018
Here’s a patent gambit for you: Roche’s Genentech unit sued Eli Lilly for infringement Tuesday, claiming the Indianapolis drugmaker’s ...
Celgene pledges to limit price hikes—or does it?
09 Jul 2018
Last October, as pharma companies ranging from Allergan to Sanofi were vowing to control price hikes, Celgene raised the prices of its cance...
We must try harder to avoid biological bias in clinical trials
09 Jul 2018
TO EVALUATE a new drug, you need a clinical trial that’s designed to most clearly reveal its effects. Test it in too variable – or too s...
Most clinical trial participants find benefits of sharing personal data outweigh risks
09 Jul 2018
Most participants in clinical trials believe the benefits of broadly sharing person-level data outweigh the risks, according to a new study ...
Medical devices: When should you make them smarter?
09 Jul 2018
The drive toward value in healthcare has increased demand for smarter medical devices able to provide information for real-time feedback, as...
How to Transfer a Medical Device to Volume Manufacturing
02 Jul 2018
After small-scale manufacturing of a new product in the lab, it must be transferred for manufacturing on a larger scale. High volume manufac...
How Fitbit is trying to transform healthcare, and itself
02 Jul 2018
Your physical and even mental health is a growing focus for Fitbit as it tries to fill the revenue gap left by a stalled business in fitness...
How medical device companies are using value-based medicine
02 Jul 2018
Jared Lewis, freelance healthcare contributor, explains how in the value-based medicine race, Xenco Medical has emerged with a novel way to ...
FDA panel rejects Pain Therapeutics’ abuse-deterrent opioid Remoxy
02 Jul 2018
Pain Therapeutics can’t seem to catch a break. On Tuesday, an FDA panel voted against the approval of Remoxy ER, its extended-release, cap...